BIOVIE INC. - Class A Common Stock, par value $0.0001 per share (BIVI)
CUSIP: 09074F405
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Class A Common Stock, par value $0.0001 per share
- Shares outstanding
- 7,932,763
- Total 13F shares
- 584
- Share change
- -1,096,394
- Total reported value
- $541
- Price per share
- $1.38
- Number of holders
- 2
- Value change
- -$1,014,622
- Number of sells
- 36
Quarterly Holders Quick Answers
What is CUSIP 09074F405?
CUSIP 09074F405 identifies BIVI - BIOVIE INC. - Class A Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09074F405:
Top shareholders of BIVI - BIOVIE INC. - Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Acuitas Group Holdings, LLC |
13D/G
|
TERREN S. PEIZER |
16%
|
3,050,394
|
$3,629,969 | $0 | 25 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
7%
|
552,369
|
$510,942 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
139,401
|
$128,948 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
1.5%
|
122,192
|
$113,028 | — | 30 Jun 2025 | |
| Jonathan M. Adams |
3/4/5
|
EVP Liver Cirrhosis Programs |
—
class O/S missing
|
48,630
|
$82,185 | — | 02 Feb 2022 | |
| Penelope Markham |
3/4/5
|
EVP Liver Cirrhosis R&D |
—
class O/S missing
|
47,841
|
$80,851 | — | 16 Feb 2023 | |
| Steve Gorlin |
3/4/5
|
Director |
—
class O/S missing
|
46,358
|
$78,345 | — | 09 Nov 2023 | |
| Christopher Reading |
3/4/5
|
EVP Neuroscience R&D |
—
class O/S missing
|
37,148
|
$62,780 | — | 16 Feb 2023 | |
| Clarence N. Ahlem |
3/4/5
|
EVP Neuroscience Product Dev. |
—
class O/S missing
|
37,148
|
$62,780 | — | 16 Feb 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.78%
|
61,742
|
$57,111 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.55%
|
43,307
|
$40,059 | — | 30 Jun 2025 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.5%
|
40,000
|
$37,000 | — | 30 Jun 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.29%
|
22,871
|
$21,156 | — | 30 Jun 2025 | |
| Richard J. Berman |
3/4/5
|
Director |
—
mixed-class rows
|
63,798
mixed-class rows
|
$19,265 | — | 20 Nov 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.25%
|
20,038
|
$18,536 | — | 30 Jun 2025 | |
| Traynor Capital Management, Inc. |
13F
|
Company |
0.23%
|
18,000
|
$16,758 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
16,022
|
$14,820 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.13%
|
10,500
|
$10,000 | — | 30 Jun 2025 | |
| DRIVE WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
10,000
|
$9,250 | — | 30 Jun 2025 | |
| Savvy Advisors, Inc. |
13F
|
Company |
0.13%
|
10,000
|
$9,250 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.09%
|
6,785
|
$6,276 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
5,525
|
$5,111 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
5,512
|
$5,099 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.06%
|
4,615
|
$4,269 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
—
class O/S missing
|
2,891
|
$2,674 | — | 30 Jun 2025 | |
| Allworth Financial LP |
13F
|
Company |
0.03%
|
2,000
|
$1,850 | — | 30 Jun 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.02%
|
1,400
|
$1,295 | — | 30 Jun 2025 | |
| Spire Wealth Management |
13F
|
Company |
0.01%
|
1,044
|
$971 | — | 30 Jun 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
963
|
$891 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
709
|
$655 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
598
|
$548 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
415
|
$384 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
395
|
$365 | — | 30 Jun 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
100
|
$93 | — | 30 Jun 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
100
|
$93 | — | 30 Jun 2025 | |
| Tradewinds Capital Management, LLC |
13F
|
Company |
0%
|
100
|
$93 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
97
|
$90 | — | 30 Jun 2025 | |
| Financial Perspectives, Inc |
13F
|
Company |
0%
|
59
|
$55 | — | 30 Jun 2025 | |
| Garde Capital, Inc. |
13F
|
Company |
0%
|
52
|
$49 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
30
|
$28 | — | 30 Jun 2025 | |
| Financial Gravity Companies, Inc. |
13F
|
Company |
0%
|
16
|
$15 | — | 30 Jun 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
15
|
$15 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
10
|
$9 | — | 30 Jun 2025 | |
| ALBION FINANCIAL GROUP /UT |
13F
|
Company |
0%
|
5
|
$5 | — | 30 Jun 2025 | |
| Caitong International Asset Management Co., Ltd |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Jun 2025 | |
| Terren S. Peizer |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
65,000
|
— | — | 23 Nov 2022 | |
| Robert J. Hariri |
3/4/5
|
Director |
—
class O/S missing
|
21,815
|
— | — | 20 Nov 2024 |
Institutional Holders of BIOVIE INC. - Class A Common Stock, par value $0.0001 per share (BIVI) as of Q3 2025
As of 30 Sep 2025,
BIOVIE INC. - Class A Common Stock, par value $0.0001 per share (BIVI) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
584 shares.
The largest 2 holders included
OSAIC HOLDINGS, INC. and Financial Perspectives, Inc.
This page lists
2
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
37
Q3 2025 holders
2
Holder diff
-35
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.